{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T03:55:31Z","timestamp":1785815731093,"version":"3.56.0"},"reference-count":37,"publisher":"American Society of Hematology","issue":"7","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,4,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Cancer survivors are at increased risk of type 2 diabetes, which usually develops from obesity and insulin resistance. Whether diabetes susceptibility is due to shared risk factors for cancer and insulin resistance or directly related to cancer and its treatment is unknown. We investigated effect modification between malignancy and body mass index (BMI) as determinants of insulin sensitivity in patients with hematologic malignancies and controls without cancer. In a cross-sectional study of 43 individuals without diabetes (20 patients with treated hematologic malignancies; 23 controls without malignancies), we measured insulin-stimulated whole-body glucose use (M) by hyperinsulinemic euglycemic clamp. Insulin sensitivity index (ISI) was calculated by dividing M over steady-state plasma insulin. Inflammatory cytokines were measured in plasma. Controls were more obese and included more non-White individuals and women vs patients with hematologic malignancies. Patients with cancer exhibited greater insulin sensitivity (median ISI, 42.4 mg\/kg\/min\/[\u03bcU\/mL]; interquartile range [IQR], 33.9-67.2 vs 23.4 mg\/kg\/min\/[\u03bcU\/mL]; IQR, 12.9-29.2; P &amp;lt; .001) and higher interleukin-6 (IL-6) and monocyte chemoattractant protein-1 (MCP-1) concentrations vs controls. Patients with cancer demonstrated greater reduction in ISI with increasing BMI vs controls, which remained significant after adjustment for sex and race (\u03b2 = \u22122.6 units; 95% confidence interval, \u22124.8 to \u22120.4; P interaction = .024). This interaction also remained significant after adjusting for log IL-6 (P interaction = .048) and log MCP-1 (P interaction = .021). Cancer survivors had disproportionately greater insulin resistance with increasing BMI vs controls without malignancies. Effect modification between cancer and BMI in determining insulin sensitivity implicated cancer-specific etiologies in glucose dysregulation and could partially explain excess diabetes diagnoses among oncology patients.<\/jats:p>","DOI":"10.1182\/bloodadvances.2021006241","type":"journal-article","created":{"date-parts":[[2022,2,7]],"date-time":"2022-02-07T20:08:42Z","timestamp":1644264522000},"page":"1981-1990","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":13,"title":["Hematologic malignancies magnify the effect of body mass index on insulin resistance in cancer survivors"],"prefix":"10.1182","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8991-3815","authenticated-orcid":false,"given":"Melis","family":"Sahinoz","sequence":"first","affiliation":[{"name":"Department of Medicine, Vanderbilt University Medical Center, Nashville, TN;"},{"name":"Veterans Administration Tennessee Healthcare System, Nashville, TN;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7225-2897","authenticated-orcid":false,"given":"James M.","family":"Luther","sequence":"additional","affiliation":[{"name":"Department of Medicine, Vanderbilt University Medical Center, Nashville, TN;"},{"name":"Division of Clinical Pharmacology, Department of Pharmacology, Vanderbilt University School of Medicine, Nashville, TN;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0331-2395","authenticated-orcid":false,"given":"Mona","family":"Mashayekhi","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Diabetes, and Metabolism, Vanderbilt University Medical Center, Nashville, TN; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dae Kwang","family":"Jung","sequence":"additional","affiliation":[{"name":"Department of Medicine, Vanderbilt University Medical Center, Nashville, TN;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5717-4218","authenticated-orcid":false,"given":"T. Alp","family":"Ikizler","sequence":"additional","affiliation":[{"name":"Department of Medicine, Vanderbilt University Medical Center, Nashville, TN;"},{"name":"Veterans Administration Tennessee Healthcare System, Nashville, TN;"},{"name":"Vanderbilt Center for Kidney Disease, Nashville, TN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian G.","family":"Engelhardt","sequence":"additional","affiliation":[{"name":"Department of Medicine, Vanderbilt University Medical Center, Nashville, TN;"},{"name":"Veterans Administration Tennessee Healthcare System, Nashville, TN;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2022,3,25]]},"reference":[{"issue":"5","key":"2022032515285855200_B1","doi-asserted-by":"crossref","first-page":"363","DOI":"10.3322\/caac.21565","article-title":"Cancer treatment and survivorship statistics, 2019","volume":"69","author":"Miller","year":"2019","journal-title":"CA Cancer J Clin."},{"issue":"8","key":"2022032515285855200_B2","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1001\/jamaoncol.2018.1684","article-title":"Incidence of diabetes after cancer development: a Korean national cohort study","volume":"4","author":"Hwangbo","year":"2018","journal-title":"JAMA Oncol."},{"issue":"1","key":"2022032515285855200_B3","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1007\/s12032-014-0422-9","article-title":"Metabolic syndrome in hematologic malignancies survivors: a meta-analysis","volume":"32","author":"Li","year":"2015","journal-title":"Med Oncol."},{"issue":"1","key":"2022032515285855200_B4","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s12933-018-0728-6","article-title":"Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007-2017","volume":"17","author":"Einarson","year":"2018","journal-title":"Cardiovasc Diabetol."},{"issue":"9524","key":"2022032515285855200_B5","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1016\/S0140-6736(06)68770-9","article-title":"Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data","volume":"367","author":"Lopez","year":"2006","journal-title":"Lancet."},{"issue":"5","key":"2022032515285855200_B6","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1172\/JCI25102","article-title":"Inflammation, stress, and diabetes","volume":"115","author":"Wellen","year":"2005","journal-title":"J Clin Invest."},{"issue":"1","key":"2022032515285855200_B7","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1172\/JCI88877","article-title":"Islet inflammation in type 2 diabetes and physiology","volume":"127","author":"Eguchi","year":"2017","journal-title":"J Clin Invest."},{"issue":"9467","key":"2022032515285855200_B8","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/S0140-6736(05)61032-X","article-title":"Type 2 diabetes: principles of pathogenesis and therapy","volume":"365","author":"Stumvoll","year":"2005","journal-title":"Lancet."},{"issue":"3","key":"2022032515285855200_B9","first-page":"E214","article-title":"Glucose clamp technique: a method for quantifying insulin secretion and resistance","volume":"237","author":"DeFronzo","year":"1979","journal-title":"Am J Physiol."},{"issue":"39","key":"2022032515285855200_B10","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.15585\/mmwr.mm6639e1","article-title":"Vital signs: trends in incidence of cancers associated with overweight and obesity - United States, 2005-2014","volume":"66","author":"Steele","year":"2017","journal-title":"MMWR Morb Mortal Wkly Rep."},{"issue":"4","key":"2022032515285855200_B11","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1172\/JCI10842","article-title":"Obesity and insulin resistance","volume":"106","author":"Kahn","year":"2000","journal-title":"J Clin Invest."},{"issue":"5","key":"2022032515285855200_B12","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.trecan.2018.03.004","article-title":"Cancer as a matter of fat: the crosstalk between adipose tissue and tumors","volume":"4","author":"Lengyel","year":"2018","journal-title":"Trends Cancer."},{"issue":"23","key":"2022032515285855200_B13","doi-asserted-by":"crossref","first-page":"2919","DOI":"10.1200\/JCO.2011.39.7356","article-title":"Management of metabolic effects associated with anticancer agents targeting the PI3K-Akt-mTOR pathway","volume":"30","author":"Busaidy","year":"2012","journal-title":"J Clin Oncol."},{"issue":"4","key":"2022032515285855200_B14","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1677\/ERC-09-0087","article-title":"Diabetes and cancer","volume":"16","author":"Vigneri","year":"2009","journal-title":"Endocr Relat Cancer."},{"issue":"6","key":"2022032515285855200_B15","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.cell.2010.01.025","article-title":"Immunity, inflammation, and cancer","volume":"140","author":"Grivennikov","year":"2010","journal-title":"Cell."},{"issue":"26","key":"2022032515285855200_B16","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1056\/NEJMoa1408617","article-title":"Age-related clonal hematopoiesis associated with adverse outcomes","volume":"371","author":"Jaiswal","year":"2014","journal-title":"N Engl J Med."},{"issue":"2","key":"2022032515285855200_B17","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJMoa1701719","article-title":"Clonal hematopoiesis and risk of atherosclerotic cardiovascular disease","volume":"377","author":"Jaiswal","year":"2017","journal-title":"N Engl J Med."},{"key":"2022032515285855200_B18","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.2337\/dc10-S062","article-title":"Diagnosis and classification of diabetes mellitus","volume":"33","author":"American Diabetes Association","year":"2010","journal-title":"Diabetes Care."},{"issue":"7","key":"2022032515285855200_B19","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1097\/00004872-199816070-00001","article-title":"How to measure insulin sensitivity","volume":"16","author":"Ferrannini","year":"1998","journal-title":"J Hypertens."},{"issue":"3","key":"2022032515285855200_B20","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.3390\/biom5031563","article-title":"Roles of chemokines and chemokine receptors in obesity-associated insulin resistance and nonalcoholic fatty liver disease","volume":"5","author":"Xu","year":"2015","journal-title":"Biomolecules."},{"key":"2022032515285855200_B21","doi-asserted-by":"crossref","first-page":"14803","DOI":"10.1038\/ncomms14803","article-title":"Temporal and tissue-specific requirements for T-lymphocyte IL-6 signalling in obesity-associated inflammation and insulin resistance","volume":"8","author":"Xu","year":"2017","journal-title":"Nat Commun."},{"issue":"3","key":"2022032515285855200_B22","doi-asserted-by":"crossref","first-page":"E289","DOI":"10.1152\/ajpendo.00430.2013","article-title":"Interleukin-1\u03b2 mediates macrophage-induced impairment of insulin signaling in human primary adipocytes","volume":"307","author":"Gao","year":"2014","journal-title":"Am J Physiol Endocrinol Metab."},{"issue":"11","key":"2022032515285855200_B23","doi-asserted-by":"crossref","first-page":"867","DOI":"10.7326\/0003-4819-110-11-867","article-title":"Adiposity, fat distribution, and cardiovascular risk","volume":"110","author":"Peiris","year":"1989","journal-title":"Ann Intern Med."},{"issue":"5","key":"2022032515285855200_B24","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1093\/ajcn\/78.5.902","article-title":"Waist circumference: a simple, inexpensive, and reliable tool that should be included as part of physical examinations in the doctor\u2019s office","volume":"78","author":"Wang","year":"2003","journal-title":"Am J Clin Nutr."},{"issue":"4","key":"2022032515285855200_B25","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1188\/16.ONF.43-04AP","article-title":"Prevalence of smoking and obesity among U.S. cancer survivors: estimates from the National Health Interview Survey, 2008-2012","volume":"43","author":"Shoemaker","year":"2016","journal-title":"Oncol Nurs Forum."},{"issue":"5","key":"2022032515285855200_B26","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1188\/12.ONF.449-457","article-title":"Diabetes and cancer: impact on health-related quality of life","volume":"39","author":"Hershey","year":"2012","journal-title":"Oncol Nurs Forum."},{"issue":"6064","key":"2022032515285855200_B27","doi-asserted-by":"crossref","first-page":"28, 30","DOI":"10.1126\/science.335.6064.28","article-title":"Cancer research. Unraveling the obesity-cancer connection","volume":"335","author":"Taubes","year":"2012","journal-title":"Science."},{"issue":"1","key":"2022032515285855200_B28","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1007\/s12032-014-0422-9","article-title":"Metabolic syndrome in hematologic malignancies survivors: a meta-analysis","volume":"32","author":"Li","year":"2015","journal-title":"Med Oncol."},{"key":"2022032515285855200_B29","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1146\/annurev.med.080708.082713","article-title":"Biological mechanisms linking obesity and cancer risk: new perspectives","volume":"61","author":"Roberts","year":"2010","journal-title":"Annu Rev Med."},{"key":"2022032515285855200_B30","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.canep.2016.06.013","article-title":"The fractions of cancer attributable to modifiable factors: a global review","volume":"44","author":"Whiteman","year":"2016","journal-title":"Cancer Epidemiol."},{"issue":"1","key":"2022032515285855200_B31","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S1470-2045(14)71123-4","article-title":"Global burden of cancer attributable to high body-mass index in 2012: a population-based study","volume":"16","author":"Arnold","year":"2015","journal-title":"Lancet Oncol."},{"issue":"35","key":"2022032515285855200_B32","doi-asserted-by":"crossref","first-page":"4270","DOI":"10.1200\/JCO.2016.67.4283","article-title":"Obesity and cancer mechanisms: tumor microenvironment and inflammation","volume":"34","author":"Iyengar","year":"2016","journal-title":"J Clin Oncol."},{"key":"2022032515285855200_B33","doi-asserted-by":"crossref","first-page":"265","DOI":"10.3389\/fonc.2017.00265","article-title":"Inflammatory signaling pathways in preleukemic and leukemic stem cells","volume":"7","author":"Hemmati","year":"2017","journal-title":"Front Oncol."},{"issue":"26","key":"2022032515285855200_B34","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1056\/NEJMoa1409405","article-title":"Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence","volume":"371","author":"Genovese","year":"2014","journal-title":"N Engl J Med."},{"issue":"6","key":"2022032515285855200_B35","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.2337\/db06-1733","article-title":"Interleukin-6 directly increases glucose metabolism in resting human skeletal muscle","volume":"56","author":"Glund","year":"2007","journal-title":"Diabetes."},{"issue":"4","key":"2022032515285855200_B36","doi-asserted-by":"crossref","first-page":"e33308","DOI":"10.1371\/journal.pone.0033308","article-title":"Measuring adiposity in patients: the utility of body mass index (BMI), percent body fat, and leptin","volume":"7","author":"Shah","year":"2012","journal-title":"PLoS One."},{"issue":"9","key":"2022032515285855200_B37","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/s11912-016-0539-4","article-title":"The obesity paradox in cancer: a review","volume":"18","author":"Lennon","year":"2016","journal-title":"Curr Oncol Rep."}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/6\/7\/1981\/1882792\/advancesadv2021006241.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/6\/7\/1981\/1882792\/advancesadv2021006241.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,25]],"date-time":"2022-03-25T15:54:17Z","timestamp":1648223657000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/6\/7\/1981\/483855\/Hematologic-malignancies-magnify-the-effect-of"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,25]]},"references-count":37,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,4,12]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2021006241","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,25]]}}}